Sanofi to launch new drugs such as Soliqua and Xenpozyme in India, focusing on expanding diabetes treatments and AI for R&D. Partnerships with Cipla and Dr Reddy's will help widen access to products such as Hexaxim and Frisium anti-epileptic drugs.
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.